Israeli scientists at Sheba Medical Center are collaborating with a leading US chip company and a major New York hospital to develop an artificial intelligence engine capable of interpreting the human genome. The project aims to use large language models, similar to those behind advanced chatbots, to analyze vast genomic datasets and provide insights into disease risks and personalized treatments based on an individual's unique genetic makeup. While only a small fraction of the genome has been fully understood so far, this initiative seeks to decode the remaining majority using advanced machine learning and computational power. The partners hope that this breakthrough will revolutionize personalized medicine, enabling more accurate drug prescriptions and tailored therapies, and potentially transforming health care for billions worldwide.